SMTL ID : 7fet.1

SARS-CoV-2 B.1.1.7 Spike Glycoprotein trimer

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

homo-trimer

Ligands

9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 3 residues within 4Å: Chain A: N.700, L.905, Q.909 No protein-ligand interaction detected (PLIP) NAG-NAG.2: 3 residues within 4Å: Chain A: N.784, S.786, Q.787 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 3 residues within 4Å: Chain A: N.1081, H.1084, F.1086 No protein-ligand interaction detected (PLIP) NAG-NAG.4: 1 residues within 4Å: Chain A: N.1117 No protein-ligand interaction detected (PLIP) NAG-NAG.5: 1 residues within 4Å: Chain C: N.692 No protein-ligand interaction detected (PLIP) NAG-NAG.6: 3 residues within 4Å: Chain C: N.700, Q.909, Q.1054 No protein-ligand interaction detected (PLIP) NAG-NAG.7: 2 residues within 4Å: Chain C: A.689, N.1057 No protein-ligand interaction detected (PLIP) NAG-NAG.8: 1 residues within 4Å: Chain C: N.1117 No protein-ligand interaction detected (PLIP) NAG-NAG.9: 1 residues within 4Å: Chain A: N.692 No protein-ligand interaction detected (PLIP)

23 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.10: 3 residues within 4Å: Chain A: Y.14, N.16, N.47 Ligand excluded by PLIP NAG.11: 2 residues within 4Å: Chain A: F.117, N.148 Ligand excluded by PLIP NAG.12: 3 residues within 4Å: Chain A: T.92, T.93, N.217 Ligand excluded by PLIP NAG.13: 2 residues within 4Å: Chain A: N.263, N.265 Ligand excluded by PLIP NAG.14: 1 residues within 4Å: Chain A: N.586 Ligand excluded by PLIP NAG.15: 1 residues within 4Å: Chain A: N.599 Ligand excluded by PLIP NAG.16: 2 residues within 4Å: Chain A: H.638, N.640 Ligand excluded by PLIP NAG.17: 1 residues within 4Å: Chain A: N.1057 Ligand excluded by PLIP NAG.18: 3 residues within 4Å: Chain B: Y.14, N.16, N.47 Ligand excluded by PLIP NAG.19: 3 residues within 4Å: Chain A: R.449 Chain B: E.116, N.148 Ligand excluded by PLIP NAG.20: 3 residues within 4Å: Chain B: N.263, E.264, N.265 Ligand excluded by PLIP NAG.21: 2 residues within 4Å: Chain B: G.322, N.326 Ligand excluded by PLIP NAG.22: 1 residues within 4Å: Chain B: N.586 Ligand excluded by PLIP NAG.23: 2 residues within 4Å: Chain B: V.598, N.599 Ligand excluded by PLIP NAG.24: 1 residues within 4Å: Chain B: N.640 Ligand excluded by PLIP NAG.25: 2 residues within 4Å: Chain B: N.314, Q.563 Ligand excluded by PLIP NAG.26: 3 residues within 4Å: Chain B: N.106, T.108, V.111 Ligand excluded by PLIP NAG.27: 2 residues within 4Å: Chain C: Y.14, N.47 Ligand excluded by PLIP NAG.28: 2 residues within 4Å: Chain C: T.92, N.217 Ligand excluded by PLIP NAG.29: 2 residues within 4Å: Chain C: N.263, N.265 Ligand excluded by PLIP NAG.30: 3 residues within 4Å: Chain C: G.322, F.325, N.326 Ligand excluded by PLIP NAG.31: 1 residues within 4Å: Chain C: N.586 Ligand excluded by PLIP NAG.32: 1 residues within 4Å: Chain C: N.599 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Xia, S. et al., Structure-based evidence for the enhanced transmissibility of the dominant SARS-CoV-2 B.1.1.7 variant (Alpha). Cell Discov (2021)

Release Date

2021-12-15

Peptides

Spike glycoprotein: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

Spike glycoprotein

Related Entries With Identical Sequence